By combining web-surveys, telephone and automated alerts, Memorial Sloan Kettering Cancer Center has been able to monitor Covid positive...

After granting €252M to CureVac, the German government has awarded €375M to BioNTech. BioNtech announcement: https://lnkd.in/dKinEe4...

Procedure volumes and hospital traffic continued to recover in August, as medtechs and investors regained confidence in increased demand...

As of July, 80% of U.S. physicians had conducted virtual consultations. Those who hadn't worry mainly about quality of care, liability...

With growing anti-vax sentiment, and regardless of the political agenda, it is critical that the industry and regulatory authorities take...

Hospital patient volumes have rebounded in August after major Covid related dips, with outpatient and surgery down 7-8% and emergency...

As digital therapeutics gain momentum, key industry players - Google Health, HP, Livongo, Philips, ResMed... - are developping...

With 50 % of global gastric, hepatic, and esophageal cancer cases and high lung cancer incidence, China Oncology market is a unique and...

Proteus, the “smart pill” unicorn, once valued at $1.5 billion, is acquired by Otsuka for $15 million. Digital Therapeutics have a great...

In post-Covid, health professionals want more support and interactions from representatives, through a mix of virtual and in-person. This...

Remote patient monitoring has dramatically increased with Covid-19 outbreak. For this to last, the technology must be easy to use by...

To reduce backlog of elective surgeries, hospitals such as Johns Hopkins are prioritizing procedures based on surgical risks, capacity...

Diabetic foot amputations increased three-fold due to interruption of DFU care during Covid-19 lock-down, according to an Italian study...

Planned $11.5 billion acquisition of QIAGEN by Thermo Fisher Scientific is terminated, as only 47.02% of Qiagen shares were tendered. The...

In a promising but risky NASH market, study shows GENFIT NIS4 easy test allows to identify patients who require treatment, without need...

Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies. For post-covid commercial restart, life science...

Usage of Biosimilars has increased significantly in Europe, while usage in the US has been lagging behind. Now, Biosimilars are finally...

Beyond the hype and quick adaptation to Covid, the future of telemedicine depends on payers' willingness to reimburse it post-pandemic,...

While orthopedic or cardiac procedures increased after April low, the pandemic continues; MedTech companies need to adapt to business...

In post-Covid, emergency medicine is moving out of emergency department, with virtual front door triage or post-discharge telehealth...